Table 1 Demographic and status of anti-DT and anti-PT IgG in the sera of subjects among different age groups
Anti-DT | Anti-PT | ||||
|---|---|---|---|---|---|
N | Positive rate (≥0.1 IU/ml) (95% CI, %) | Concentration and 95% CI (IU/ml) | Positive rate (≥40 IU/ml) (95% CI, %) | Concentration and 95% CI (IU/ml) | |
Gender | |||||
Male | 324 | 48.15 (42.76–53.58) | 0.37 (0.32–0.43) | 8.03 (5.53–11.50) | 13.44 (9.20–17.67) |
Female | 160 | 50.00 (42.34–57.66) | 0.40 (0.31–0.49) | 5.63 (2.99–10.34) | 11.43 (6.32–16.54) |
p | 0.7014 | 0.4594 | 0.3376 | 0.7663 | |
Age | |||||
< 6 m | 133 | 34.59 (27.04–43.0) | 0.19 (0.14–0.24) | 8.27 (4.68–14.20) | 11.76 (7.88–15.65) |
6 m- < 3y | 159 | 68.55 (60.97–75.26) | 0.56 (0.47–0.66) | 7.55 (4.37–12.73) | 12.59 (7.72–17.46) |
3y- < 6y | 100 | 40.00 (30.94–49.80) | 0.62 (0.45–0.79) | 5.00 (2.15–11.18) | 10.34 (4.02–16.66) |
≥6y | 92 | 45.65 (35.88–55.80) | 0.44 (0.31–0.57) | 7.61 (3.73–14.88) | 12.32 (5.47–19.17) |
p | < 0.0001 | < 0.0001 | 0.7776 | < 0.0001 | |
Total | 484 | 48.97 (44.54–53.41) | 0.38 (0.33–0.43) | 7.23 (5.25–9.89) | 11.85 (9.21–14.48) |